
Company valuation, historical trends, and peer comparisons.
According to CStone Pharmaceuticals’s latest financial reports and current stock price. The company's current Enterprise Value is 6.59B. This represents a change of 36.27% compared to the average of 4.84B of the last 4 quarters.
The mean historical Enterprise Value of CStone Pharmaceuticals over the last ten years is 6.73B. The current 6.59B Enterprise Value has changed -2.02% with respect to the historical average. Over the past ten years (40 quarters), CSPHF's Enterprise Value was at its highest in in the June 2021 quarter at 14.06B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.
Average
6.73B
Median
6.50B
Minimum
1.96B
Maximum
11.27B
Discovering the peaks and valleys of CStone Pharmaceuticals Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 126.31%
Maximum Annual Enterprise Value = 11.27B
Minimum Annual Increase = -56.54%
Minimum Annual Enterprise Value = 1.96B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 6.17B | 126.31% |
| 2024 | 2.72B | 38.69% |
| 2023 | 1.96B | -56.54% |
| 2022 | 4.52B | -37.81% |
| 2021 | 7.27B | 22.65% |
| 2020 | 5.93B | -13.38% |
| 2019 | 6.84B | -33.47% |
| 2018 | 10.28B | -0.49% |
| 2017 | 10.33B | -8.27% |
The current Enterprise Value of CStone Pharmaceuticals (CSPHF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
3.62B
5-year avg
4.53B
10-year avg
6.73B
CStone Pharmaceuticals’s Enterprise Value is greater than HUTCHMED (China) Limited (2.53B), greater than Zai Lab Limited (2.52B), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (740.82M), less than Shanghai Henlius Biotech, Inc. (26.64B), less than Mabwell-b (10.12B), less than InnoCare Pharma Limited (11.75B), greater than Edding Genor Group Holdings Limited (2.94B), less than Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (91.09B), greater than Nanjing Leads Biolabs Co Ltd (5.84B), greater than Antengene Corporation Limited (1.02B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 2.53B | $19.92B | |
| 2.52B | $22.56B | |
| 740.82M | $1.21B | |
| 26.64B | $27.67B | |
| 10.12B | $10.28B | |
| 11.75B | $18.22B | |
| 2.94B | $3.15B | |
| 91.09B | $110.38B | |
| 5.84B | $7.45B | |
| 1.02B | $1.80B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CStone Pharmaceuticals using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CStone Pharmaceuticals or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is CStone Pharmaceuticals's Enterprise Value?
What is the highest Enterprise Value for CStone Pharmaceuticals (CSPHF)?
What is the 3-year average Enterprise Value for CStone Pharmaceuticals (CSPHF)?
What is the 5-year average Enterprise Value for CStone Pharmaceuticals (CSPHF)?
How does the current Enterprise Value for CStone Pharmaceuticals (CSPHF) compare to its historical average?